Who are Mona Lisa® NT Cu380 Mini's main competitors?

No direct comparators detected in our index.

How often does this brief refresh?

Every 30 minutes from primary sources (FDA, EMA, MHRA, PMDA, ClinicalTrials.gov, USPTO). Subscribe to the RSS feed below for push alerts.

How do I get this as a recurring report?

Subscribe to /feed/ci/mona-lisa-nt-cu380-mini.xml in any RSS reader (Feedly, Inoreader, NewsBlur). Every regulatory action, trial readout, or patent event lands in your feed automatically.

Last reviewed 2026-05-16 · How we verify

Mona Lisa® NT Cu380 Mini — Competitive Intelligence Brief

Mona Lisa® NT Cu380 Mini (Mona Lisa® NT Cu380 Mini) competitive landscape: 0 comparators, recent regulatory actions, upcoming PDUFA, patent timeline. Class: Intrauterine device (IUD), copper-based contraceptive. Area: Contraception / Reproductive Health.

phase 3 Intrauterine device (IUD), copper-based contraceptive Contraception / Reproductive Health Small molecule Live · refreshed every 30 min

Target snapshot

Mona Lisa® NT Cu380 Mini (Mona Lisa® NT Cu380 Mini) — FHI 360. A copper-containing intrauterine device that prevents pregnancy by releasing copper ions that create a hostile environment for sperm and embryo implantation.

Comparator set

Auto-detected by same drug class / molecular target / therapeutic area, ranked by phase + recency. Override with ?vs=slug1,slug2,….

Drug	Generic	Sponsor	Phase	Class	Target	Approval / PDUFA
Mona Lisa® NT Cu380 Mini TARGET	Mona Lisa® NT Cu380 Mini	FHI 360	phase 3	Intrauterine device (IUD), copper-based contraceptive

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape (Intrauterine device (IUD), copper-based contraceptive class)

FHI 360 · 1 drug in this class

Subscribe to ongoing alerts

Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:

Cite this brief

Drug Landscape (2026). Mona Lisa® NT Cu380 Mini — Competitive Intelligence Brief. https://druglandscape.com/ci/mona-lisa-nt-cu380-mini. Accessed 2026-05-16.

Build your own brief

Pick any drug + add comparators:

https://druglandscape.com/ci/{slug} — auto-detected competitors
https://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3 — explicit comparators
Brand names auto-resolve: /ci/keytruda → 301 → /ci/pembrolizumab